A 6-Week Randomized, Multicenter, Double-Blind, Parallel, Fixed-Dose Study of MG01CI 1400mg Compared with Placebo in Adults with Attention Deficit/Hyperactivity Disorder (ADHD)

  • Glaser, Paul (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date4/2/14 → 2/28/15